GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Praxsyn Corp (GREY:PXYN) » Definitions » Buyback Yield %

Praxsyn (Praxsyn) Buyback Yield % : 0.00 (As of May. 13, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Praxsyn Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Praxsyn's current buyback yield was 0.00%.


Praxsyn Buyback Yield % Historical Data

The historical data trend for Praxsyn's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Praxsyn Buyback Yield % Chart

Praxsyn Annual Data
Trend Oct05 Oct06 Oct07 Oct08 Oct09 Dec10 Dec11 Dec12 Dec13 Dec14
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.95 -8.60 -26.01 -3.44 1.87

Praxsyn Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Praxsyn's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Praxsyn's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Praxsyn's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Praxsyn's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Praxsyn's Buyback Yield % falls into.



Praxsyn Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Praxsyn's Buyback Yield for the fiscal year that ended in Dec. 2014 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-0.506 + 0) / 27.11334
=1.87%

Praxsyn's annualized Buyback Yield for the quarter that ended in Sep. 2015 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0) * 4 / 12.67848
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Sep. 2015) data.


Praxsyn Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Praxsyn's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Praxsyn (Praxsyn) Business Description

Traded in Other Exchanges
N/A
Address
61 Spectrum Boulevard, Suite A, Las Vegas, NV, USA, 89101
Praxsyn Corp is a healthcare company, dedicated to providing medical practitioners with medications and services for their patients. Through its retail pharmacy facility, it formulates healthcare practitioner-prescribed medications to serve patients who experience chronic pain. It primarily focuses on non-narcotic and non-habit forming medications using therapeutic and preventative agents for pain management. In addition, the group prepares innovative products that address erectile dysfunction and metabolic issues and other ancillary products. The products of the firm are either picked up directly from pharmacy facility or shipped directly to patients. The business activities are functioned through the regions of United States.

Praxsyn (Praxsyn) Headlines

From GuruFocus

Update: Praxsyn's Coronavirus Mask Demand.

By GlobeNewswire GlobeNewswire 03-04-2020

Praxsyn Capital First Portfolio Funding

By Marketwired Marketwired 10-03-2019

Praxsyn Launches Credit Card Processing.

By Marketwired Marketwired 11-14-2019

Praxsyn Adds Board Members, Issues Corporate Update

By Marketwired Marketwired 09-25-2018

Praxsyn Capital Operational in New York.

By Marketwired Marketwired 11-18-2019